TD Cowen Boosts Acadia Healthcare (NASDAQ:ACHC) Price Target to $36.00

Acadia Healthcare (NASDAQ:ACHC) had its target price raised by investment analysts at TD Cowen from $30.00 to $36.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. TD Cowen’s target price would suggest a potential upside of 18.75% from the company’s previous close.

A number of other research analysts also recently commented on the stock. KeyCorp increased their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday. Cantor Fitzgerald upped their price objective on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Jefferies Financial Group raised Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $24.50 to $30.00 in a report on Wednesday, June 3rd. Barclays boosted their target price on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, April 30th. Finally, UBS Group upped their target price on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and a consensus target price of $28.69.

Acadia Healthcare Stock Down 0.8%

NASDAQ ACHC traded down $0.24 during trading on Tuesday, reaching $30.32. 795,424 shares of the company’s stock were exchanged, compared to its average volume of 3,347,555. The company has a 50 day moving average price of $26.15 and a two-hundred day moving average price of $22.00. The stock has a market cap of $2.79 billion, a P/E ratio of -2.46, a price-to-earnings-growth ratio of 10.43 and a beta of 0.64. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $32.82. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. During the same quarter in the prior year, the business posted $0.40 EPS. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities research analysts anticipate that Acadia Healthcare will post 1.5 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

A number of large investors have recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Acadia Healthcare during the first quarter worth about $1,600,000. Goldman Sachs Group Inc. increased its holdings in Acadia Healthcare by 21.1% in the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after buying an additional 121,444 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after acquiring an additional 27,207 shares during the period. American Century Companies Inc. grew its holdings in shares of Acadia Healthcare by 531.5% in the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after acquiring an additional 88,995 shares during the period. Finally, Prudential Financial Inc. grew its holdings in shares of Acadia Healthcare by 21.9% in the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after acquiring an additional 1,780 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.